Mitsubishi Tanabe Pharma - M&A Summary and Business Overview

Life ScienceCompany

Mitsubishi Tanabe Pharma M&A Summary

Mitsubishi Tanabe Pharma has acquired 2 companies.

Mitsubishi Tanabe Pharma’s largest acquisition to date was in 2017, when it acquired NeuroDerm for $1.1B. Mitsubishi Tanabe Pharma has acquired in 2 countries. The Company’s most targeted sectors include life science (100%).

Mitsubishi Tanabe Pharma Business Overview

Where is Mitsubishi Tanabe Pharma headquartered?

Mitsubishi Tanabe Pharma is headquartered in Osaka, Japan.

What is Mitsubishi Tanabe Pharma’s revenue?

Mitsubishi Tanabe Pharma disclosed revenue of 424,767M JPY for 2019 and 433,855M JPY for 2018.

How many employees does Mitsubishi Tanabe Pharma have?

Mitsubishi Tanabe Pharma has 6,728 employees.

What sector is Mitsubishi Tanabe Pharma in?

Mitsubishi Tanabe Pharma is a life science company.

When was Mitsubishi Tanabe Pharma founded?

Mitsubishi Tanabe Pharma was founded in 1933.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2

Mitsubishi Tanabe Pharma

Mitsubishi Tanabe Pharma Corp.

3-2-10, Dosho-machi, Chuo-ku,
Osaka, 541-8505
Japan,
+81 6 6205 5211
www.mt-pharma.co.jp

Mitsubishi Tanabe Pharma is a research-driven pharmaceutical company that specializes in the research, development, and marketing of globally competitive pharmaceutical products focused on the field of autoimmune disease, diabetes and kidney disease, and CNS disease. Mitsubishi Tanabe Pharma was founded in 1933 and is based in Osaka, Japan.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 2 - - - - - 2
vol $1.1B $1.1B
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
NeuroDerm Ltd. 2017-07-24 1.1B USD Add-on Acquisition
Rehovot, Israel · www.neuroderm.com
Medicago, Inc. 2013-09-13 - Add-on Acquisition
Quebec, Quebec · www.medicago.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 1.1B (100%) - -
Total 2 $1.1B - -

By Geo

State/Country Buy Value Sell Value
Canada 1 - - -
  Quebec 1 - - -
Israel 1 1.1B - -
Domestic - - - -
Cross-border 2 (100%) 1.1B (100%) - -
Total 2 $1.1B - -

Deal Values

buy # Total
> $1B 1 $1.1B
TOTAL $1.1B
Largest NeuroDerm Ltd.
$1.1B (2017-07-24)

 Subscribe to unlock this and 202,424
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Mitsubishi Tanabe Pharma

Life Science Companies , Japan Companies